A new marketplace wants to rescue shelved cell and gene therapies . Written byAndrea Corona

A new marketplace wants to rescue shelved cell and gene therapies CGTxchange pairs an AI-enabled evaluation platform with ASGCT's global network to connect deprioritized rare disease programs with new sponsors and investors. Written byAndrea Corona https://www.drugdiscoverynews.com/a-new-marketplace-wants-to-rescue-shelved-cell-and-gene-therapies-17168 Hundreds of cell and gene therapies (CGTs) that showed clinical promise have been shelved in recent years — not because they failed patients, but because they failed to meet traditional commercial return expectations. A new joint venture announced January 7, 2026, is attempting to create an alternative pathway for those programs.